Categories
Blood Cancer

The role of selinexor in the treatment of multiple myeloma [Video]

The role of selinexor in the treatment of multiple myeloma

In this video, Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the role of selinexor in the treatment of multiple myeloma, emphasizing its value in patients with del(17p)-positive relapsed/refractory (R/R) disease. Dr Richardson also highlights some of the challenges associated with the use of selinexor, and clinical trials evaluating the safety and efficacy of this agent. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Watch/Read More
Categories
Blood Cancer

How to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma [Video]

Ezzat El Hassadi, MD, University Hospital Waterford, Waterford, Ireland, outlines the challenges associated with treatment sequencing in multiple myeloma, commenting on the remarkable efficacy of CAR-Ts in this setting, and highlighting the possibility to incorporate CAR-T therapy earlier in the treatment algorithm of multiple myeloma. This interview was recorded virtually. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.